Top compounds associated with response to C20orf96


Feature Type Standardized
Nominal ANOVA
mRNA Axitinib CTRPv2 pan-cancer AAC 0.18 5e-07
mRNA FQI-2 CTRPv2 pan-cancer AAC 0.17 6e-07
mRNA tipifarnib CTRPv2 pan-cancer AAC 0.16 6e-07
mRNA FK866 CTRPv2 pan-cancer AAC 0.2 7e-07
mRNA BI-2536 CTRPv2 pan-cancer AAC 0.16 8e-07
mRNA BRD-K70511574 CTRPv2 pan-cancer AAC 0.16 9e-07
mRNA SB-225002 CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.15 1e-06
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA parbendazole CTRPv2 pan-cancer AAC 0.16 1e-06
Download CSV